Similarly, CDK4, linked to cell cycle regulation and associated with a poor prognosis in chondrosarcoma, can be targeted by palbociclib or CDK4-specific siRNA, which significantly reduces tumor cell proliferation and spread via cell cycle arrest. The gene discussed is CDK4; the disease is neoplasm.